PGIM India Healthcare Fund - Regular (IDCW)
Last Updated NAV Date: 30 Jul 2026
3 Year Returns
N/A
NAV (₹)
11.9000
1 Day NAV Change
0.00%
No chart data available for this period.
Fund Details
| Min. SIP Amount | ₹ 1000 |
| Min. Lumpsum Amount | ₹ 5000 |
| AUM | ₹ 103.24 Cr |
| Expense Ratio | 2.53% |
| Lock-in Period | No Lock-in Period |
| Inception Date | 06 Dec 2024 |
| Fund Age | 1 Yrs |
Exit Load
For Exits within 90 days from date of allotment of units: 0.50% For Exits beyond 90 days from date of allotment of units: NIL
Fund’s Investment Objective
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns.
Calculate Your Mutual Fund Returns
Returns Estimator
Estimation is based on the past performance
Expected Rate of Return
The value of your investment after 5 Years will be
₹4,12,432
Invested Amount
₹3,00,000
Est. Returns
₹1,12,432
Scheme’s Historical Return
1 Month Return5.59%
3 Month Return16.67%
6 Month Return28.93%
1 Year Return16.78%
Asset Allocation
AUM
₹1,33,309.00 Cr
Cash Holdings
21.45%
Equity
70.84%
Cash
21.45%
Debt
1.71%
Other
6%
Sector Holdings
Last Updated: 30 Jun 2026| Sectors | Allocation | Weightage | Value (in Cr.) |
|---|---|---|---|
| Pharmaceuticals | 66.78% | ₹ 68.94 | |
| Healthcare | 27.79% | ₹ 28.687 | |
| Chemicals | 3.19% | ₹ 3.293 | |
| Insurance | 1.07% | ₹ 1.1 | |
| FMCG | 0.69% | ₹ 0.717 | |
| IT - Software | 0.48% | ₹ 0.499 |
Stock Holdings
Last Updated: 30 Jun 2026| Name | Allocation | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|---|
| Sun Pharma.Inds. | 10.86% | ₹ 11.21 | Pharmaceuticals | |
| Divi's Lab. | 9.14% | ₹ 9.434 | Pharmaceuticals | |
| Max Healthcare | 6.52% | ₹ 6.726 | Healthcare | |
| Aster DM Health. | 6.41% | ₹ 6.619 | Healthcare | |
| J B Chemicals & | 6.40% | ₹ 6.609 | Pharmaceuticals | |
| Ajanta Pharma | 5.56% | ₹ 5.738 | Pharmaceuticals | |
| Mankind Pharma | 5.19% | ₹ 5.357 | Pharmaceuticals | |
| Krishna Institu. | 4.12% | ₹ 4.256 | Healthcare | |
| Rubicon Research | 3.99% | ₹ 4.12 | Pharmaceuticals | |
| C C I | 3.19% | ₹ 3.297 | Debt Others |
Fund Manager Details
More than 16 years of experience in the Debt markets within the Mutual Fund space. Below are details on his past stints: December 13, 2017 onwards - Deputy Head - Fixed Income - DHFL Pramerica Asset Managers Private Limited. February 2012 to December 12, 2017 - Head - Fixed Income - BNP Paribas Asset Management India Pvt. Ltd. July 2008 to February 2012 - Sr. Vice President & Fund Manager - UTI Asset Management Company Ltd. August 2006 to July 2008 - Fund Manager - Tata Asset Management Ltd. April 2004 to August 2016 - Asst. Fund Manager - UTI Asset Management Company Ltd. June 2001 to March 2004 - Dealer - UTI Asset Management Company Ltd. MBA(finance)from SIBM,Pune.
Over 15 years of experience in capital market October 01, 2013 - till date: Reliance Capital Asset Management Ltd. Assistant Fund Manager ( Fixed Income Investments) February 2010 to September 2013: Reliance Capital Asset Management Ltd. - Dealer (Fixed Income Investment) May 2007 to February 2010: Reliance Capital Asset Management Ltd - Assistant Manager (Fixed Income Investment) June 2006 to April 2007: Reliance Capital Asset Management Ltd. - Management Trainee Sales and Distributions B.E (Electronic), PGDBM - Finance
Collectively over 13 years of experience in Indian financial markets, primarily in equity research: June 2021 onwards - PGIM India Asset Management Pvt. Ltd. - Equity Analyst and Asst. Fund Manager January 2020 to May 2021 - PGIM India Asset Management Pvt. Ltd. - Equity Analyst and Dedicated Fund Manager - Overseas Investments March 2019 to January 2020 - PGIM India Asset Management Pvt. Ltd. - Equity Analyst May 2018 to March 2019 - Renaissance Investment Managers Private Ltd. - Equity Analyst August 2010 to May 2018 - Canara Robeco Asset Management Company Ltd. - Equity Analyst September 2009 to August 2010 - Canara Robeco Asset Management Company Ltd. - Fixed Income Dealer B Com, ACA, CFA, FRM
Over 14 years of experience in Equity market, research and fund management. October 23, 2023 onwards -PGIM India Asset Management Pvt Ltd. Vice President, Fund Manager Equity. September 2018 to October 2023 Edelweiss Asset Management Ltd. VP Alternatives. June 2014 to September 2018 Ambit Capital Sector Analyst Institutional Equities.January 2014 2014 MF Advisors LLP Analyst Investments. November 2012 December 2013 Ambit Capital Associate Investment Research. B.Com., CFA
Risk-O-Meter
Very High Risk
Investors understand that their principal will be at Very High Risk
Risk Scale
Low
Moderately Low
Moderate
Moderately High
High
Very High
AMC Information
PGIM India Mutual Fund
Funds Managed
25
Assets Managed
₹ 26,639.93 Cr
Contact Details
Registered Address
4th Floor, C Wing, Laxmi Towers,Bandra Kurla Complex,Bandra (East), Mumbai - 400 051
Managing Director
N/A
Chief Executive Officer
Abhishek Tiwari
Compliance Officer
Mr. Sandeep Kamath
Mutual Funds Calculators
Explore Mutual Funds by Types
Open NFOs
Explore Popular AMCs
SBI Mutual FundICICI Prudential Mutual FundHDFC Mutual FundNippon India Mutual FundKotak Mahindra Mutual FundAditya Birla Sun Life Mutual FundUTI Mutual FundAxis Mutual FundDSP Mutual FundMirae Asset Mutual FundTata Mutual FundBandhan Mutual FundEdelweiss Mutual FundPPFAS Mutual FundMotilal Oswal Mutual FundInvesco Mutual FundHSBC Mutual FundFranklin Templeton Mutual FundCanara Robeco Mutual FundQuant Mutual FundSundaram Mutual FundBaroda BNP Paribas Mutual FundLIC Mutual FundWhiteOak Capital Mutual Fund
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
You can withdraw your investment from PGIM India Healthcare Fund - Regular (IDCW) through your mutual fund app, AMC website, or demat or stock broker online account at the applicable NAV.
The minimum investment for PGIM India Healthcare Fund - Regular (IDCW) is ₹ 5000 for Lumpsum and ₹ 1000 for SIP. You can open a demat account or login to the existing stock broker online account to get started.
PGIM India Healthcare Fund - Regular (IDCW) has a lock-in period of No Lock-in Period. Schemes with a lock-in restrict withdrawals or redemptions for that duration, while schemes with no lock-in allow you to redeem anytime.
The average annualized return of PGIM India Healthcare Fund - Regular (IDCW) over the past three years is N/A.
The current NAV of PGIM India Healthcare Fund - Regular (IDCW) is 11.9000.
The Expense ratio of PGIM India Healthcare Fund - Regular (IDCW) is 2.53%. It is an annual charge for running the mutual fund. You can find the same on the factsheet and the Asset Management Companies website.
The latest AUM of the PGIM India Healthcare Fund - Regular (IDCW) fund is ₹ 103.24 Cr. It represents the total assets held and managed by the fund.
The exit load for PGIM India Healthcare Fund - Regular (IDCW) is For Exits within 90 days from date of allotment of units: 0.50% For Exits beyond 90 days from date of allotment of units: NIL.
The fund managers of the PGIM India Healthcare Fund - Regular (IDCW) are Puneet Pal, Vivek Sharma, Anandha Padmanabhan Anjen, Utsav Mehta. However, with management's discretion, the fund manager could also change during the tenure.
PGIM India Healthcare Fund - Regular (IDCW) was launched on 06 Dec 2024. Since then, the fund has formed an NAV (Net Asset Value) of 11.9000.
Download the AR Invest App
- 5000+ Schemes
- Personalized Solutions
- Expert Insights
